MEDP  valuation analysis

Basics
Name: Medpace Holdings, Inc
Description: Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 15, 2021
Market cap: $6.32B (621st)
Sales(TTM): $925.92M (1009th)
Earnings(TTM): $145.38M (653rd)

Value
FFER: 1.20 (why)
Actual price: $177.83
FFEThis is Medpace Holdings, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $135.66
Quantile: MEDP is expensive given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Medpace Holdings, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Medpace Holdings, Inc
"Diagnostics & Research" industry
Book / MarketCap
Medpace Holdings, Inc
"Diagnostics & Research" industry
Equity / Assets
Medpace Holdings, Inc
"Diagnostics & Research" industry